Introduction
Hepatitis A virus (HAV) infection occurs throughout the world but most common in developing countries. 1 In these countries with high endemicity, 90% of the population is infected by 10 years of age. 2 Here children are continuously exposed to the virus, which confers lifelong immunity. 3 In many developing countries like India, Pakistan, Nepal several sero-prevalence studies have shown high rates of sero-positivity among child by sub-clinical infection 4-9 . Therefore, mass vaccination against HAV has not been recommended in endemic countries. 10 Furthermore, Hepatitis-A vaccine is expensive. In Bangladeshi children, limited data are available regarding the sero-prevalence of HAV antibody. 11 In this context, the present study was designed to see the prevalence of HAV antibody (IgG & IgM) among children of different age group and to perform a cost benefit analysis study before formulating a vaccination strategy for the children of Bangladesh. Total 172 children from 1-5 year age group, 55 children from 5-10 year age group and 27 children from 10-15 year age group were taken. Boys were 139 & girls 115 so male:female ratio was 1.2: 1. Age distribution of the children positive for HAV antibody shows that with the advancement of age, anti-HAV positivity increases. Anti-HAV of 1-5 year age group was found to be 44.7%, it gradually increased to 70.9% in 5-10 year age group and finally to 92.6% in 10-15 year age group. Anti-HAV positivity of 5-10 year age group was significantly higher than that of 1-5 year age group (p=0.001) and antibody positivity of 10-15 year age group was significantly higher than that of 5-10 year age group (p=0.026). (Table 1 .1). 
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